Tobacco-vax making comes to Texas; India promises crackdown on fakes in New Delhi;

> Count the Texas A&M Health Science Center among those building tobacco-based vaccine manufacturing facilities. Article

> India's chief minister Sheila Dikshit promises an action plan to crack down on spurious drugs in the country's capital, New Delhi. Article

> New Jersey-based Pristine Pharma is moving manufacturing to Massena, NY. Article

> China's drug regulator has granted a manufacturing license to Hebei Aoxing API Pharmaceutical Co., a joint venture of Aoxing Pharma and Macfarlan Smith. Release

> A doubling of production by the biomedical industry led Singapore's manufacturing output to a 31-percent rise over a year earlier. Article

> India's chief minister Sheila Dikshit promises an action plan to crack down on spurious drugs in the country's capital, New Delhi. Article

> World Health Organization officials say fakes and poor storage conditions are driving resistance to malaria drugs. Story

> Aurora Pharmaceutical has completed construction of a 65,000-square-foot facility in Northfield, MN, for manufacturing oral medications, disinfectants and topical preparations for animals. Article

> Armenia is working on a project to stimulate domestic pharmaceutical manufacturing. Story

> Southern Sudan is revamping its pharma supply system with labs and monitoring units to prevent the smuggling of counterfeits. Story

> Sanofi Aventis is using OYSTAR Hüttlin HTG 1800 and HD 600 units in a granulating line for production of acetaminophen tablets. Release

> Datex has announced an IT-support service for users of the FootPrint warehouse management system software. Release

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.